GlobalData on MSN1d
OXcan raises $11m to develop liquid biopsy tests for early cancer detection
Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for early cancer detection. This investment increases OXcan's total funding to ...
New FDA rules to cut racial bias in some, but not all, devices to measure oxygen in the blood
Pulse oximeters helped drive racial inequities in care during the pandemic, but many devices at drugstores and online won’t ...
Healio2d
Competitive Bidding Program not linked to supplemental oxygen use, COPD outcome changes
No link was found between Competitive Bidding Program implementation and changes in supplemental oxygen use or clinical ...
New FDA rules to reduce racial bias in some common devices measuring oxygen in blood
At a CVS store in a racially diverse neighborhood in Brooklyn Center, the only devices available to shoppers to measure their ...